Differences in toxicity of the catechol-O-methyl transferase inhibitors, tolcapone and entacapone to cultured human neuroblastoma cells.
D001577:Benzophenones / Q000494:pharmacology / Q000633:toxicity*; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000494:pharmacology / Q000633:toxicity*; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D004272:DNA, Mitochondrial / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000633:toxicity*; D006801:Humans; D009447:Neuroblastoma / Q000201:enzymology*; D009570:Nitriles; D009596:Nitrophenols; D000077867:Tolcapone; D014407:Tumor Cells, Cultured
D001577:Benzophenones; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D004272:DNA, Mitochondrial; D004791:Enzyme Inhibitors; D009570:Nitriles; D009596:Nitrophenols; C071192:entacapone; D000077867:Tolcapone; D002394:Catechol O-Methyltransferase